Relative Effects of α- and γ-Tocopherol on Low-Density Lipoprotein Oxidation and Superoxide Dismutase and Nitric Oxide Synthase Activity and Protein Expression in Rats
Background: Increasing evidence suggests that vitamin E prevents the progression of ath erosclerosis by inhibiting platelet aggregation, monocyte adhesion. and improving plaque stability and vasomotor function. Recently, controversy has arisen as to the relative effects of α- and γ-tocopherol in modulating some mediators of atherosclerosis.
Methods and Results: We examined the effects of α- and γ-tocopherol on constitutive nitric oxide synthase (cNOS) and superoxide dismutase (SOD) activity and protein expression in rats. Sprague-Dawley rats were fed regular chow or chow mixed with α- or γ-tocopherol (100 mg/kg/ day) for 7 to 10 days. Plasma α- and γ-tocopherol levels, low-density lipoprotein (LDL) oxida tion, and cNOS and SOD activity and protein expression were measured. Plasma α-tocopherol levels were significantly increased (P < .01 vs control), but γ-tocopherol levels fell (P < .01 vs control) in rats fed α-tocopherol. Plasma γ-tocopherol levels were increased (P < .01 vs con trol), and α-tocopherol levels did not change in rats fed γ-tocopherol. Both α- and γ-tocopherol feeding decreased the rate of LDL oxidation induced by phorbol 12-myristate 13-acetate (PMA)-stimulated leukocytes (P < .01 vs control). Both α- and γ-tocopherol increased SOD activity in plasma and arterial tissues as well as Mn SOD and Cu/Zn SOD protein expression in arterial tissues (all P < .01 vs control). γ-Tocopherol was more potent than α-tocopherol in all these effects (P < .05). Both a- and γ-tocopherol increased NO generation and cNOS activity (all P < .05 vs control). However, only γ-tocopherol increased cNOS protein expression.
Conclusions: These observations indicate that whereas both α- and γ-tocopherol exert important effects on determinants of oxidation and vasomotor function, effects of dietary α-tocopherol supplementation in vivo are less pronounced than those of γ-tocopherol supplementation.
Stampfer MJ, Hennekens CH, Manson JE, et al. Vitamin E consumption and the risk of coronary disease in women . N Engl J Med328:1444, 1993
2.
Rimm EB, Stampfer MJ, Ascherio A., et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med328:1450,1993
3.
Kushi LH, Folsom AR, Prineas RJ, et al. Dietary antioxidant vitamins and death from cardiac vascular disease in post-menopausal women. N Engl J Med334:1156, 1996
4.
Stephens NG, Parsons A., Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet347:781, 1996
5.
Diaz MN, Frei B., Vita JA, Keaney JF Jr.Antioxidants and atherosclerotic heart disease. N Engl J Med337:408, 1997
6.
Keaney JF Jr, Guo Y., Cunningham D., et al. Vascular incorporation of alpha-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation. J Clin Invest98:386, 1996
7.
Keaney JF Jr, Xu A., Cunningham D., et al. Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation. J Clin Invest95:2520, 1995
8.
Fuster V., Badimon L., Badimon JJ, Chesebro JHThe pathogenesis of coronary artery disease and the acute coronary syndromes . N Engl J Med326:310, 1992
9.
Conti CR, Mehta JLAcute myocardial ischemia: Role of atherosclerosis, in situ thrombosis, platelet activation, coronary vasospasm, and altered arachidonic acid metabolism . Circulation75 (suppl V):V84, 1987
10.
Ikeda H., Koga Y., Oda T., et al. Free oxygen radicals contribute to platelet aggregation and cyclic flow variations in stenosed and endothelium-injured canine coronary arteries . J Am Coll Cardiol24:1749, 1994
11.
Jourdan A., Aguejour O., Imbault P., et al. Experimental thrombosis model induced by free radicals. Application to aspirin and other different substances. Thromb Res79:109, 1995
12.
Mehta JP, Li DY, Liu W., Mehta JLProlongation of time to arterial thrombosis by vitamin C and E in rats. J Nutr129:109,1999
13.
Moncada S., Higgs E., Palmer R.Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev43:109, 1991
14.
Rubanyi GM, Vanhoutte PMSuperoxide anions and hyperoxia inactivate endothelium-derived relaxing factor . Am J Physiol250:H822, 1986
15.
Freedman JE , Farhat JH, Loscalzo J., Keaney JFAlpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism . Circulation10:2434, 1996
16.
Wolf G. Gamma-tocopherol : An efficient protector of lipids against nitric oxide-initiated peroxidative damage. Nutr Rev55:376, 1997
17.
Christen S. , Woodall AA, Siiigenaga MK, et al. γ-Tocopherol traps mutagenic electrophiles such as NOx and complements α-tocopherol: Physiological implications. Proc Natl Acad Sci USA94:3217, 1997
18.
Ohrvall M., Sundlof G., Vessby B.Gamma, but not alpha, tocopherol levels in serum are reduced in coronary disease patients. J Intern Med239:111, 1996
19.
Handleman GJ , Machlin LJ, Fitch G., et al. Oral α-tocopherol supplements decrease plasma γ-tocopherol in humans. J Nutr115:807, 1985
20.
Chen LY, Haught WH, Yang BC, et al. Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine. J Am Coll Cardiol30:569, 1997
21.
Li DY, Yang BC, Mehta JLOxidized low density lipoprotein induces apoptosis in cultured human coronary artery endothelial cells: Role of PKC, PTK, bcl-2, and Fas. Am J Physiol275:H568, 1998
22.
Chen LY, Mehta P., Mehta JLOxidized LDL decreases L-arginine uptake and nitric oxide synthase protein expression in human platelets: Relevance of the effect of oxidized LDL on platelet function. Circulation93:1740, 1996
23.
Ylä-Herttuala S., Palinski W., Rosenfeld ME, et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest84:1086,1989
24.
Chin JH, Azhar S., Hoffman BBInactivation of endothelium-derived relaxing factor by oxidized lipoproteins . J Clin Invest89:10, 1992
25.
Kugiyama K. , Kerns SA, Morrisett JD, et al. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature (Lond) 344:160,1990
26.
Morel DW, Hessler GM, Chisolm GMLow density lipoprotein cytotoxicity induced by free radicals peroxidation of lipid. J Lipid Res24:1070,1983
27.
Quinn MT, Parthasarathy S., Fong LG, Steinberg D.Oxidatively modified low density lipoprotein: A potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci USA84:2995, 1987
28.
Gryglewski RJ, Palmer RM, Moncada S.Superoxide anion is involved in the breakdown of endolethium-derived vascular relaxing factor . Nature (Lond) 320:454, 1986
29.
Nishio E., Watanabe Y.Oxysterols-induced apoptosis in cultured smooth muscle cells through CPP32 protease activation and bcl-2 protein downregulation. Biochem Biophys Res Commun226:928,1996
30.
Yang X., Galeano NF, Szaboles M., et al. Oxidized low density lipoproteins alter macrophage lipid uptake, apoptosis, viability and nitric oxide synthesis. J Nutr126: 10272s, 1996
31.
Jialal I., Devaraj S.The role of oxidized low density lipoprotein in atherogenesis. J Nutr126:1053S, 1996
32.
Minor RL, Myers PR, Guerra R., et al. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest86:2109, 1990
33.
Liao F., Andalibi A., Qiao JH, et al. Genetic evidence for a common pathway mediating oxidative stress inflammatory gene induction, and aorta fatty streak formation in mice. J Clin Invest94:877, 1994
34.
Mehta JL, Nichols WW, Saldeen Tgp, et al. Superoxide dismutase decreases reperfusion arrhythmias and preserves myocardial function during thrombolysis with tissue plasminogen activator . J Cardiovasc Pharmacol16:112, 1990
35.
Islam KN, Devaraj S., Jialal I.α-Tocopherol enrichment of monocytes decreases agonist-induced adhesion to human endothelial cells. Circulation98:2255, 1998
36.
Faure P., Rossini E., Lafond JL, et al. Vitamin E improves the free radical defense system potential and insulin sensitivity of rats fed high fructose diets. J Nutr127:103,1997
37.
Lopez-Ongil S., Hernandez-Perera O., Navarro-Antolin J., Perez-de-Lema G.Role of reactive oxygen species in the signalling cascade of cyclosporine A-mediated up-regulation of eNOS in vascular endothelial cells. Br J Pharmacol124:447, 1998
38.
Borrello S. , Demple B.NF kappaB-independent transcriptional induction of the human manganous superoxide dismutase gene. Arch Biochem Biophys348:289,1997
39.
Das KC, Lewis-Molock Y., White CWThiol modulation of TNF alpha and IL-1 induced MnSOD gene expression and activation of NF-kappa B. Mol Cell Biochem148:45, 1995
40.
Bowry VW, Ingold KU, Stocker R.Vitamin E in human low-density lipoprotein. When and how this anti-oxidant becomes a pro-oxidant. Biochem J288:341, 1992
41.
Yamakura F. , Taka H., Fujimura T., et al. Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine. J Biol Chem273:14085, 1998
42.
Cooney RV, Franke AA, Harwood PJ, et al. Gamma-tocopherol detoxification of nitrogen dioxide: Superiority to alpha-tocopherol. Proc Natl Acad Sci USA90:1771, 1993
